据智研咨询统计显示，中国椎间孔镜行业市场规模由2020年的2.78亿元增长至2023年的2.84亿元，同比增长2.16%。但从市场前景来看，国内椎间孔镜市场增长空间极为可观。该手术适应症包括腰椎间盘突出症、腰椎管狭窄症、神经根型颈椎病等疾病，覆盖老年、青年以及儿童群体，病人基数非常大。今海医疗科技何晓表示，最早微创手术占脊柱手术比重不到10%，随着后续政策的推进，微创手术占比能提升至30%，甚至50%以上。Jinhai Med Tech (02225) Chief Marketing Officer He Xiao's team held a training session at Shanghai Ruijin Hospital to discuss and exchange views on Jinhai's Parallia endoscopic spine technology.
According to the Securities Times app, on October 18-19, Jinhai Med Tech (02225) Chief Marketing Officer He Xiao's team held a training session at Shanghai Ruijin Hospital to discuss and exchange views on Jinhai's Parallia endoscopic spine technology. This training includes topics such as endoscopic spine technology, single-hole double-channel dual-medium endoscopic vertebral arch hard dural block excision surgery, endoscopic treatment of lumbar spinal stenosis, UBE endoscopic fusion technology, robot-assisted arthroscopic lumbar fusion surgery, etc.
As an innovative force in the medical and health field, Jinhai Med Tech (02225) has achieved significant success in the high-end endoscope field with its outstanding technical strength. Star products such as 4K 3D fluorescence endoscope are widely used. Relying on its deep accumulation in endoscopic technology, Jinhai Med Tech has steadily entered the field of intervertebral foramenoscope and minimally invasive spine field to achieve diversification in endoscope products and applications.
According to Wisdom Research statistics, the market size of the intervertebral foramenoscope industry in China has increased from 0.278 billion yuan in 2020 to 0.284 billion yuan in 2023, a year-on-year growth of 2.16%. However, in terms of market prospects, the domestic intervertebral foramenoscope market has considerable growth space. The indications for this surgery include lumbar disc herniation, lumbar spinal stenosis, nerve root cervical spondylosis and other diseases, covering a large number of elderly, young, and children. He Xiao from Jinhai Med Tech stated that minimally invasive surgery initially accounted for less than 10% of spinal surgeries. With the advancement of subsequent policies, the proportion of minimally invasive surgery can be increased to 30% or even more than 50%.
It is understood that in endoscopic spine surgery, the intervertebral foramenoscope surgery has the advantage of minimally invasive, but it has high technical difficulty and strict requirements for doctors' proficiency. For Jinhai Med Tech to enter the field of minimally invasive intervertebral technology, it must cooperate with top experts, teaching hospitals, and major tertiary teaching hospitals nationwide to promote technology and enhance education. The training session held by Jinhai's Parallia in collaboration with Shanghai Ruijin Hospital is an important measure to promote education in the intervertebral technology market for Jinhai Med Tech.
It is worth mentioning that this clinical training used Jinhai's Parallia's minimally invasive spine surgery clinical instruments, combined with Jinhai Med Tech's advanced imaging and display systems. This combination not only demonstrated excellent application effects in clinical operations, but also reflected the effective coordination and cooperation between endoscopic imaging and display systems with endoscopic spine technology. From the strategic perspective of the entire Jinhai Med Tech listed company, this clinical training marks the close cooperation between Jinhai Med Tech and its invested enterprise Jinhai's Parallia, and is also an important exercise for the future collaborative operation of the two product lines of Jinhai Med Tech's development.
